IDXX
NASDAQ · Health Care
Idexx Laboratories Inc
$541.31
-4.42 (-0.81%)
Financial Highlights (FY 2026)
Revenue
4.19B
Net Income
1.03B
Gross Margin
61.8%
Profit Margin
24.6%
Rev Growth
+8.5%
D/E Ratio
0.53
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 61.8% | 61.8% | 31.9% | 31.9% |
| Operating Margin | 31.6% | 28.4% | 14.6% | 15.3% |
| Profit Margin | 24.6% | 23.4% | 10.3% | 10.9% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 4.19B | 3.86B | 10.62B | 11.63B |
| Gross Profit | 2.59B | 2.39B | 3.39B | 3.71B |
| Operating Income | 1.32B | 1.10B | 1.55B | 1.78B |
| Net Income | 1.03B | 855.43M | 1.10B | 1.27B |
| Gross Margin | 61.8% | 61.8% | 31.9% | 31.9% |
| Operating Margin | 31.6% | 28.4% | 14.6% | 15.3% |
| Profit Margin | 24.6% | 23.4% | 10.3% | 10.9% |
| Rev Growth | +8.5% | +8.5% | +24.1% | +5.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 7.66B | 7.66B | 3.29B | 3.69B |
| Total Equity | 14.51B | 14.51B | 41.52B | 37.24B |
| D/E Ratio | 0.53 | 0.53 | 0.08 | 0.10 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.47B | 1.28B | 2.07B | 2.23B |
| Free Cash Flow | — | — | 651.24M | 734.03M |